全球医药领先品牌_肿瘤特效药_抗癌新药_靶向药物_全球医药咨询-【健康光环全球医药】 -

Respiratory department

Brensoctib: Managing Side Effects of the Novel DPP-1 Inhibitor for Bronchiectasis

2026-05-20 02:43:58

Explore the safety profile of Brensoctib, a first-in-class DPP-1 inhibitor for neutrophil-mediated inflammatory diseases. This guide details the management of dermatological, periodontal, and infection risks during treatment.

Check Details

A Comprehensive Guide to Benralizumab Adverse Reactions: Prevention and Management

2026-05-06 03:26:04

Benralizumab (Fasenra) is generally safe for severe eosinophilic asthma, but potential risks exist. This guide covers common side effects (headache, sore throat), hypersensitivity, infection risks, and rare severe reactions, providing actionable strategies for patients and clinicians.

Check Details

A Third-Gen EGFR-TKI Transforming Lung Cancer Treatment

2026-03-30 07:09:03

Sunvozertinib, a next-gen EGFR-TKI, offers breakthrough efficacy for EGFR-mutated NSCLC patients. Designed to overcome resistance and tackle brain metastases, it provides a promising new option. Explore dosing guidelines, AE management, monitoring strategies, and long-term treatment insights.

Check Details